Landec Corporation  

(Public, NASDAQ:LNDC)   Watch this stock  
Find more results for LNDC
11.92
+0.04 (0.34%)
Real-time:   3:13PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 11.13 - 12.19
52 week 9.84 - 13.26
Open 12.05
Vol / Avg. 35,538.00/175,234.00
Mkt cap 313.90M
P/E 19.33
Div/yield     -
EPS 0.62
Shares 26.87M
Beta 1.09
Inst. own 91%
Dec 31, 2014
Q2 2015 Landec Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Oct 9, 2014
Landec Corp Annual Shareholders Meeting
Oct 8, 2014
Q1 2015 Landec Corp Earnings Call
Oct 7, 2014
Q1 2015 Landec Corp Earnings Release
Sep 23, 2014
Landec Corp at Wedbush Securities CA Dreamin' Consumer Conference: "The NY Edition"
Sep 18, 2014
Landec Corporation at Imperial Capital Global Opportunities Conference
Sep 4, 2014
Landec Corporation at Liolios Group Gateway Conference
Jul 30, 2014
Q4 2014 Landec Corp Earnings Call
Jul 29, 2014
Q4 2014 Landec Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Aug '14) 2014
Net profit margin 1.81% 4.06%
Operating margin 2.64% 4.23%
EBITD margin - 5.73%
Return on average assets 2.82% 6.40%
Return on average equity 4.29% 10.03%
Employees 531 -
CDP Score - -

Address

3603 Haven Avenue
MENLO PARK, CA 94025
United States - Map
+1-650-3061650 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Landec Corporation (Landec) designs, develops, manufactures and sells polymer products for food and agricultural products, medical devices and licensed partner applications that incorporate Landec's polymer technologies. The Company has two polymer technology platforms: Intelimer polymers, and hyaluronan (HA) biopolymers. The Intelimer polymer is a crystalline, hydrophobic polymer. Hyaluronan is a non-crystalline, hydrophilic polymer. Landec operates in four business segments: Apio, Inc. (Apio) with the Food Products Technology and Food Export businesses, Lifecore Biomedical, Inc., with the HA Biomaterials business and Landec's Technology Licensing business. On April 23, 2012, Apio acquired GreenLine Holding Company (GreenLine). On June 24, 2012, the Company sold Landec Ag LLC to INCOTEC Holding North America, Inc.

Officers and directors

Gregory S. Skinner Chief Financial Officer, Vice President - Finance and Administration
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nicholas Tompkins Chairman of the Board of Apio, Inc., Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Molly A. Hemmeter Chief Operating Officer
Age: 46
Bio & Compensation  - Reuters
Steven P. Bitler Ph.D. Vice President - Corporate Technology
Age: 56
Bio & Compensation  - Reuters
Larry D. Hiebert Vice President, President of Lifecore Biomedical, Inc.
Age: 58
Bio & Compensation  - Reuters
Ronald Lane Midyett Vice President; President, Chief Executive Officer of Apio, Inc.
Age: 48
Bio & Compensation  - Reuters
Gary T. Steele Director
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert D. Bolles Ph.D. Independent Director
Age: 57
Bio & Compensation  - Reuters
Frederick Frank Independent Director
Age: 82
Bio & Compensation  - Reuters
Steven D. Goldby Independent Director
Age: 74
Bio & Compensation  - Reuters